Nanjing, China

Sicong Lin

This inventor holds 1 USPTO granted patent. Top assignee: Gy Bio-Materials Co., Ltd.. Active years: 2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sicong Lin. Retrieved from https://idiyas.com/inventor/sicong-lin-diufcvi1

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2018

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Sicong Lin - Innovator in Blood-Friendly Polymer Technology

Introduction

Sicong Lin is a notable inventor based in Nanjing, China. He has made significant contributions to the field of biomedical materials, particularly through his innovative work on blood-friendly polymers. His research focuses on developing materials that enhance compatibility with biological systems.

Latest Patents

Sicong Lin holds a patent for a "Bondable blood-friendly polymer and preparing method thereof." This invention involves a bondable blood-friendly polymer that is a terpolymer or quadripolymer formed from polyethylene glycol alkyl ether acrylate or methacrylate, zwitterionic acrylic ester or methacrylic ester, and various functional groups. The polymer is designed to improve blood compatibility while addressing the challenges posed by hydrophobic chain links. The disclosed polymer coating not only overcomes existing defects but also enhances blending properties.

Career Highlights

Sicong Lin is currently associated with Gy Bio-Materials Co., Ltd., where he continues to advance research in biomaterials. His work has the potential to significantly impact medical applications, particularly in devices that require blood compatibility.

Collaborations

Sicong Lin collaborates with talented individuals such as Hui Zhou Lin and Wei Wu, contributing to a dynamic research environment focused on innovative solutions in biomaterials.

Conclusion

Sicong Lin's contributions to the field of blood-friendly polymers exemplify the importance of innovation in biomedical materials. His work not only addresses critical challenges but also paves the way for future advancements in medical technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…